9788418892912. Manual de psiquiatría clínica_5ed

277

Trastornos del neurodesarrollo y otros trastornos de la infancia

Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis; study design and baseline characteristics. Aust N Z J Psy chiatry . 2009;43:818–829. Preti A, Cella M. Randomized-controlled trails in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res . 2010;123:30–36. Rapoport JL, Gogtay N. Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci . 2011;29: 251–258. Remschmidt J, Theisen FM. Early-onset schizophrenia. Neuropsychobio logy . 2012;66:63–69. Schimmelmann BG, Schmidt AJ, Carbon M, Correll CU. Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach. Curr Opin Psychia try . 2013;26:219–230. Seal JL, Gornick MC, Gotgay N, Shaw P, Greenstein DK, Coffee M, Gochman PA, Stromberg T, Chen Z, Merriman B, Nelson SF, Brooks J, Arepalli S, Wavrant-De Vrieze F, Hardy J, Rapoport JL, Adding ton AM. Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia. J Med Genet . 2006;43(11): 887–892. Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P, Tossell JW, Lenane M, Rapoport JL. Childhood onset schizophrenia: a double-blind clozapine-olanzapine comparison. Arch Gen Psychiatry . 2006;63:721–730. Shrivastava A, McGorry PD, Tsuang M, Woods SW, Cornblatt BA, Cor coran C, Carpenter W. “Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: the debate. Indian J Psychiatry . 2011;53:57–65. Sikich L. Early onset psychotic disorders. In: Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan & Sadock’s Comprehensive Textbook of Psychia try . 9th ed. Vol. 2. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:3699. Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman JA. Double-blind compari son of first-and second-generation antipsychotics in early-onset schi zophrenia and schizoaffective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry . 2008;165:1420–1431. Starling J, Williams LM, Hainsworth C, Harris AW. The presentation of early-onset psychotic disorders. Aust N Z J Psychiatry . 2013;47:43–50. Vyas NS, Gogtay N. Treatment of early onset of schizophrenia: recent trends, challenges and future considerations. Front Psychiatry . 2012; 3:1–5. Vyas NS, Patel NH, Puri BK. Neurobiology and phenotypic expres sion in early-onset schizophrenia. Early Interv Psychiatry . 2011; 5:3–14. Yung AR, Phillips LJ, Nelson B, Francey SM, Panyuen H, Simmons MB, Ross ML, Kelly D, Baker K, Amminger GP, Berger G, Thompson AD, Thampi A, McGorry PD. Randomized controlled trial of interventions for young people at ultra-high risk for psychosis: 6-month analysis. J Clin Psychiatry . 2011;72:430–440. Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lut ter F. Wither the attenuated psychosis syndrome? Schizophr Bull . 2012;38:1130–1134.

Trastornos por consumo de sustancias Buckner JD, Heimberg RG, Schneier FR, Liu SM, Want S, Blanco C. The relationship between cannabis use disorder and social anxiety disorder in the National Epidemiologic Study of Alcohol and Related Condi tions (NESARC). Drug Alcohol Depend . 2012;124:128–134. Bukstein O. Adolescent substance abuse. In: Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan & Sadock’s Comprehensive Textbook of Psychia try . 9th ed. Vol. II. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:3818. Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Lim C, Whittle L, Brener ND, Wechsler H; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance—United States, 2009. MMWR Surveill Summ . 2010;59(5):1–142. Fiorentini A, Volunteri LS, Draogna F, Rovera C, Maffini M, Mauri MC, Altamura CA. Substance-induced psychoses: a critical review of the literature. Curr Drug Abuse Rev . 2011;4:228–240. Fraser S, Hides L, Philips L, Proctor D, Lubman DI. Differentiating first episode substance induced primary psychotic disorders with concurrent substance use in young people. Schizophr Res . 2012;136:110–115. Giedd J, Stocvkman M, Weele C. Anatomic magnetic resonance imaging of the developing child and adolescent brain. In: Reyna VF; Chapman SB, Dougherty MR, Copnfrey J, eds. The Adolescent Brain: Learning, Reasoning, and Decision Making . Washington, DC: American Psycho logical Association; 2012. Harrow BS, Tompkins CP, Mitchell PD, Smith KW, Soldz S, Kasten L, Fleming K. The impact of publicly funded managed care on adoles cent substance abuse treatment outcomes. Am J Drug Alcohol Abuse . 2006;32(3):379. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future: National Survey Results on Drug Use. 1975–2007. Vol 3 Secondary School Students. Bethesda, MD. National Institute on Drug Abuse; 2008. KaminerY,Winters KC. Proposed DSM-5 substance use disorders for ado lescents: If you build it, will they come? Am J Addict . 2012;21:280–281. Lenk KM, Erickson DJ, Wonters KC, Nelson TF, Toomey TL. Screening services for alcohol misuse and abuse at four-year colleges in the U.S. J Subst Abuse Treat . 2012;43:352–358. McCabe SE, West BT, Teter CJ, Boyd CJ. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med . 2012;166:797–802. Mitchell SG, Gryczynski J, Gonzales A, Moseley A, Peterson T, O’Grady KE, Schwartz RP. Screening, brief intervention, and referral to treatment (SBIRT) for substance use in a school-based program: services and out comes. Am J Addict . 2012;21:S5–S13. Tavolacci MP, Ladner J, Grigioni S, Richard L, Villet H, Dechelotte P. Prevalence and association of perceived stress, substance use and beha vioral addictions: a cross-sectional study among university students in France, 2009–2011. BMC Public Health . 2013;13:724–732. Winters KC. Advances in the science of adolescent drug involvement: implications for assessment and diagnosis—experience from the Uni ted States. Curr Opin Psychiatry . 2013;26:318–324. Winters KC, Martim CS, Chung T. Substance use disorders in DSM-V. When applied to adolescents. Addiction . 2011;106:882–884.

Yuma-Guerrero PJ, Lawson KA, Velasquez MM, von Sternberg K, Max son T, Garcia N. Screening, brief intervention, and referral for alcohol use in adolescents: a systematic review. Pediatrics . 2012;130:115–122. SAMPLE